Atlas Trials

Study Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-Administered

Clinical trial NCT00745576 · COMPLETED

Trial details

NCT number
NCT00745576
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2008-10-01
Primary completion
2008-12-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.